Assessment of renal function in clinical practice at the bedside of burn patients

British Journal of Clinical Pharmacology

Volumn 63, Issue 5, 2007, Pages 583-594

  Conil, J M ^a,b   Georges, B ^a,b   Fourcade, O ^b   Seguin, T ^b   Lavit, M ^a,c   Samii, K ^b   Houin, G ^a,c   Tack, I ^b   Saivin, S ^a,c  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU RANGUEIL   (France)

^c Institut Federatif de Biologie   (France)

Author keywords

Burn patients; Creatinine clearance; Glomerular filtration rate; Prediction equations; Serum creatinine

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BODY WEIGHT; BURN; BURN PATIENT; CLINICAL ARTICLE; CLINICAL PRACTICE; COCKCROFT GAULT EQUATION; CREATINE KINASE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; KIRKPATRICK EQUATION; LENGTH OF STAY; MALE; MATHEMATICAL PARAMETERS; MODIFICATION OF RENAL DISEASE EQUATION; PATIENT ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; ROBERT EQUATION; SEX DIFFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; BURNS; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRAUMA SEVERITY INDICES;

EID: 34247327462     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02807.x     Document Type: Article

References (49)

1. Ronco C, Bellomo R. Prevention of acute renal failure in the critically ill. Nephron Clin Pract 2003 93 : C13 20.
2. Loirat P, Rohan J, Baillet A, Beaufils F, David R, Chapman A. Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin. N Engl J Med 1978 299 : 915 9.
3. Ecklund J, Grandberg P, Liljedahl S. Studies on renal function in burns. Acta Chirurgica Scand 1979 136 : 627 40.
4. Weinbren MJ. Pharmacokinetics of antibiotics in burns patients. J Antimicrob Chemother 2001 47 : 720.
5. Lipman J, Wallis SC, Boots RJ. Cefepime vs. cefpirome: the importance of creatinine clearance. Anesth Analg 2003 97 : 1149 54.
6. Highet VS, Forrest A, Ballow CH, Schentag JJ. Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy. J Antimicrob Chemother 1999 43 (Suppl A 55 63.
7. Kashuba AD, Ballow CH, Forrest A. Development and evaluation of a Bayesian pharmacokinetic estimator and optimal, sparse sampling strategies for ceftazidime. Antimicrob Agents Chemother 1996 40 : 1860 5.
8. Vinks AA, Mouton JW, Touw DJ, Heijerman HG, Danhof M, Bakker W. Population pharmacokinetics of ceftazidime in cystic fibrosis patients analyzed by using a nonparametric algorithm and optimal sampling strategy. Antimicrob Agents Chemother 1996 40 : 1091 7.
9. Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002 8 : 509 14.
10. Hoste EA, Damen J, Vanholder RC, Lameire NH, Delanghe JR, Van den Hauwe K, Colardyn FA. Assessment of renal function in recently admitted critically ill patients with normal serum creatinine. Nephrol Dial Transplant 2005 20 : 747 53.
11. Dailly E, Pannier M, Jolliet P, Bourin M. Population pharmacokinetics of ceftazidime in burn patients. Br J Clin Pharmacol 2003 56 : 629 34.
12. Dailly E, Kergueris MF, Pannier M, Jolliet P, Bourin M. Population pharmacokinetics of imipenem in burn patients. Fundam Clin Pharmacol 2003 17 : 645 50.
13. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992 38 : 1933 53.
14. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
15. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 70.
16. Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985 28 : 830 8.
17. Bauer JH, Brooks CS, Burch RN. Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate. Am J Kidney Dis 1982 2 : 337 46.
18. Kellen M, Aronson S, Roizen MF, Barnard J, Thisted RA. Predictive and diagnostic tests of renal failure: a review. Anesth Analg 1994 78 : 134 42.
19. Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 1987 82 : 945 52.
20. Aronoff GR, Berns JS, Brier ME. Drug prescribing in renal failure. Dosing guidelines for adults, 4th edition. Philadelphia, American College of Physicians-American Society of Internal Medicine 1999.
21. Kasiske BL, Keane WF. Laboratory assessment of renal disease: Clearance, urinalysis, and renal biopsy. In Saunders, J, ed. The Kidney. Philadelphia, Brenner and Rector, 2000, 1129 70.
22. Drug Information Branch CfDEaR. Guidance for Industry: Pharmacokinetics in patients with impaired renal function. Study design, data analysis, and impact on dosing and labeling. 1998.
23. Robert S, Zarowitz BJ, Peterson EL, Dumler F. Predictability of creatinine clearance estimates in critically ill patients. Crit Care Med 1993 21 : 1487 95.
24. Kirkpatrick CM, Duffull SB, Begg EJ. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 1999 47 : 637 43.
25. Duffull SB, Dooley MJ, Green B, Poole SG, Kirkpatrick CM. A standard weight descriptor for dose adjustment in the obese patient. Clin Pharmacokinet 2004 43 : 1167 78.
26. Matthews I, Kirkpatrick C, Holford N. Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Br J Clin Pharmacol 2004 58 : 8 19.
27. Kidney Disease Outcome Quality Initiative. K/DOQI clinical practice guidelines for chronic kidney disease. Evaluation, Classification, and Stratification. Am J Kidney Dis 2002 2 (Suppl 2 S1 S246.
28. Agarwal R, Vasavada N, Chase SD. Liquid chromatography for iothalamate in biological samples. J Chromatogr B Anal Technol Biomed Life Sci 2003 785 : 345 52.
29. Levey AS, Greene T, Kusek JW, Beck GJA. Simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000 11 : 155A.
30. Conil J, Saivin S, Georges B, Samii K, Houin G. Ceftazidime drug monitoring by population pharmacokinetic approach in burn patients. Anesthesiologists ASo Annual Meeting, San Francisco, CA 2003.
31. Lund CC, Browder NC. The estimation of areas of burns. Surg Gynecol Obstet 1944 79 : 352 8.
32. Stern M, Waisbren BA. Comparison of methods of predicting burn mortality. Scand J Plast Reconstr Surg 1979 13 : 201 4.
33. Sachs A, Watson J. Four years' experience at a specialised burns centre. The Mcindoe Burns Centre 1965-68. Lancet 1969 1 : 718 21.
34. Tobiasen J, Hiebert JH, Edlich RF. Prediction of burn mortality. Surg Gynecol Obstet 1982 154 : 711 4.
35. Devine B. Gentamicin therapy. Drug Intell Clin Pharm 1974 8 : 650 5.
36. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 1 : 307 10.
37. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm 1981 9 : 503 12.
38. Delanghe J, De Slypere JP, De Buyzere M, Robbrecht J, Wieme R, Vermeulen A. Normal reference values for creatine, creatinine, and carnitine are lower in vegetarians. Clin Chem 1989 35 : 1802 3.
39. Sjostrom PA, Odlind BG, Wolgast M. Extensive tubular secretion and reabsorption of creatinine in humans. Scand J Urol Nephrol 1988 22 : 129 31.
40. Grotsch H, Hajdu P. Interference by the new antibiotic cefpirome and other cephalosporins in clinical laboratory tests, with special regard to the 'Jaffe' reaction. J Clin Chem Clin Biochem 1987 25 : 49 52.
41. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003 14 : 2573 80.
42. Lott RS, Uden DL, Wargin WA, Strate RG, Zaske DE. Correlation of predicted versus measured creatinine clearance values in burn patients. Am J Hosp Pharm 1978 35 : 717 20.
43. Bonate PL. Pathophysiology and pharmacokinetics following burn injury. Clin Pharmacokinet 1990 18 : 118 30.
44. Martyn J. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology 1986 65 : 67 75.
45. Curreri PW, Richmond D, Marvin J, Baxter CR. Dietary requirements of patients with major burns. J Am Diet Assoc 1974 65 : 415 7.
46. Sosa JL, Ward CG, Hammond JS. The relationship of burn wound fluid to serum creatinine and creatinine clearance. J Burn Care Rehabil 1992 13 : 437 42.
47. O'Connell MB, Dwinell AM, Bannick-Mohrland SD. Predictive performance of equations to estimate creatinine clearance in hospitalized elderly patients. Ann Pharmacother 1992 26 : 627 35.
48. Annat G, Viale JP, Bui Xuan B, Hadj Aissa O, Benzoni D, Vincent M, Gharib C, Motin J. Effect of PEEP ventilation on renal function, plasma renin, aldosterone, neurophysins and urinary ADH, and prostaglandins. Anesthesiology 1983 58 : 136 41.
49. Berkhout J, Visser LG, van den Broek PJ, van de Klundert JA, Mattie H. Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion. Antimicrob Agents Chemother 2003 47 : 1862 6.